Back to health guides
Unbranded tablets and a capped injection pen in a South African consultation setting
Weight Loss & Medicines · 2 min read

Weight-loss Tablets vs Injections: What to Ask About New Treatments

Prepared by Online Doctor editorial teamPublished

Separate international medicine news from South African registration, supply and individual suitability.

News about an oral weight-loss medicine can make it sound as though injections are already obsolete. The practical questions are more specific: what product is being discussed, where is it approved and does the evidence apply to your health needs?

New international developments are not local approvals

The US FDA announced approval of oral orforglipron, branded Foundayo, in April 2026. In October 2026, the EMA’s medicines committee recommended a marketing authorisation. These are jurisdiction-specific developments, not proof of South African registration, routine availability or medical-aid cover.

A tablet is not automatically the same treatment

Formulations can differ in their approved uses, evidence, instructions and adverse effects. The ingredient name alone does not establish that a diabetes tablet has the same weight-management indication as another formulation. Do not compare milligram numbers across different products as though they were equivalent doses.

Ask what is established and what remains uncertain

Request the current South African professional information for any medicine being proposed. Ask which outcomes were studied, what monitoring would be needed and whether treatment is available through a licensed pharmacy. Research results and marketing headlines should not be treated as a personalised prediction.

Choose a pathway rather than a headline

Explain your preferences, including concerns about injections, medicine routines, cost and follow-up. A clinician can discuss locally appropriate options without promising a particular new medicine. Do not order an overseas product or stop existing treatment merely because another formulation is attracting attention.

Key Takeaways

  • International approval does not establish South African access.
  • Tablets and injections are not automatically interchangeable.
  • Check formulation-specific evidence and instructions.
  • Discuss current local options with a clinician.

Sources & further reading

General health information; speak with a qualified healthcare professional for advice about your own care.